G3BP2
Ras GTPase-activating protein-binding protein 2
Also known as: G3BP2_HUMAN, KIAA0660
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UN86
- Gene
- G3BP2
- Ensembl
- ENSG00000138757
- Chromosome
- 4
- Canonical length
- 482 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Enables molecular condensate scaffold activity. Involved in positive regulation of stress granule assembly; protein homooligomerization; and stress granule assembly. Located in cytoplasmic stress granule and cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
482 residues, UniProt reviewed canonical sequence.
>Q9UN86|G3BP2
1 MVMEKPSPLL VGREFVRQYY TLLNKAPEYL HRFYGRNSSY VHGGVDASGK PQEAVYGQND
61 IHHKVLSLNF SECHTKIRHV DAHATLSDGV VVQVMGLLSN SGQPERKFMQ TFVLAPEGSV
121 PNKFYVHNDM FRYEDEVFGD SEPELDEESE DEVEEEQEER QPSPEPVQEN ANSGYYEAHP
181 VTNGIEEPLE ESSHEPEPEP ESETKTEELK PQVEEKNLEE LEEKSTTPPP AEPVSLPQEP
241 PKAFSWASVT SKNLPPSGTV SSSGIPPHVK APVSQPRVEA KPEVQSQPPR VREQRPRERP
301 GFPPRGPRPG RGDMEQNDSD NRRIIRYPDS HQLFVGNLPH DIDENELKEF FMSFGNVVEL
361 RINTKGVGGK LPNFGFVVFD DSEPVQRILI AKPIMFRGEV RLNVEEKKTR AARERETRGG
421 GDDRRDIRRN DRGPGGPRGI VGGGMMRDRD GRGPPPRGGM AQKLGSGRGT GQMEGRFTGQ
481 RRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against G3BP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- tongue: 112 nTPM
- skeletal muscle: 97 nTPM
- cerebral cortex: 84 nTPM
- prostate: 73 nTPM
- thyroid gland: 70 nTPM
- bone marrow: 65 nTPM
Single-cell type
- myonuclei: 796 nCPM
- late spermatids: 341 nCPM
- platelets: 341 nCPM
- early spermatids: 266 nCPM
- innate lymphoid cells: 252 nCPM
- t-cells: 243 nCPM
Immune cell
- basophil: 83 nTPM
- MAIT T-cell: 76 nTPM
- non-classical monocyte: 64 nTPM
- total PBMC: 64 nTPM
- eosinophil: 63 nTPM
- NK-cell: 60 nTPM
Brain region
- hypothalamus: 167 nTPM
- cerebral cortex: 156 nTPM
- basal ganglia: 130 nTPM
- pons: 128 nTPM
- midbrain: 120 nTPM
- white matter: 117 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.61
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nuclear transport factor 2 domain
- Nucleotide-binding alpha-beta plait domain superfamily
- Nuclear transport factor 2, eukaryote
- NTF2-like domain superfamily
- RNA-binding domain superfamily
- Ras GTPase-activating protein-binding protein
- RNA recognition motif
- Nuclear transport factor 2 (NTF2) domain
- G3BP2, RNA recognition motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of G3BP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads G3BP2 as an antibody target. Whether an autoantibody or antibody against G3BP2 could matter depends on whether native G3BP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
G3BP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label G3BP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...